Trial intelligence / Profile preview

Procoagulant Effect of Tenecteplase vs Alteplase vs Streptokinase in AMI

NCT02182011Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
May 2000
Primary completion
Jun 2001
Modality
rProtein (Recombinant Protein), Biologic
01

Overview

A Phase 3 trial of tenecteplase in myocardial infarction (MI), sponsored by Boehringer Ingelheim. Started May 2000; status: completed.

02

Drugs

tenecteplase
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT02182011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02182011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call